Tech Company Financing Transactions
Hamilton Pharmaceuticals Funding Round
Hamilton Pharmaceuticals, operating out of Bethesda, scored $11 million from CNF Investments, Index Ventures and Vivo Capital.
Transaction Overview
Company Name
Announced On
4/22/2005
Transaction Type
Venture Equity
Amount
$11,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds of the Series A funding will be used for the clinical study of HL-0812, and to further strengthen the product portfolio through in-licensing activities.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
3 Bethesda Metro Center 700
Bethesda, MD 20814
USA
Bethesda, MD 20814
USA
Phone
Website
Email Address
Overview
Hamilton Pharmaceuticals, Inc. (HPI) is a product-based specialty pharmaceutical company engaged in the development and commercialization of novel medical treatments for central nervous system disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Executive Vice President
Larry Glass
Browse more venture capital transactions:
Prev: 4/22/2005: RMD Networks venture capital transaction
Next: 4/22/2005: TargetRx venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs